ICHM | Conference

New Therapies for T-Cell Lymphomas on the Horizon
February 28, 2017

There is a critical need for new therapies for T-cell lymphomas, and with ongoing trials of mTOR and aurora kinase inhibitors, PI3K inhibitors, and others, new options may be on the horizon.

Emerging Therapies in the Treatment of Multiple Myeloma
February 28, 2017

In this interview we discuss the latest therapy developments in the treatment of multiple myeloma.

Novel Antibody-Based Therapies Emerge for AML
February 27, 2017

A handful of novel antibody-based therapies may soon emerge for the treatment of acute myeloid leukemia, according to a presentation at the 21st Annual International Congress on Hematologic Malignancies.